Full Text View
Tabular View
No Study Results Posted
Related Studies
Mitomycin as a Hyperthermic Peritoneal Perfusion in Treating Patients With Malignant Ascites
This study has been terminated.
( Withdrawn due to slow accrual )
Study NCT00265863   Information provided by Masonic Cancer Center, University of Minnesota

First Received on December 14, 2005.   Last Updated on November 6, 2012   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Metastatic Cancer
Additional conditions recognized in this trial
Ascites
Fever
Neoplasm Metastasis
Neoplasms
Neoplasms, Second Primary
More general conditions related to this trial
Body Temperature Changes
Neoplastic Processes
Pathologic Processes
Signs and Symptoms
Interventions listed in this trial
mitomycin C
Additional drug interventions recognized in this trial
Mitomycin
Mitomycins
More general drug interventions related to this trial
Alkylating Agents
Antibiotics, Antineoplastic
Antineoplastic Agents
Enzyme Inhibitors
Molecular Mechanisms of Pharmacological Action
Nucleic Acid Synthesis Inhibitors
Pharmacologic Actions
Therapeutic Uses
Sponsors listed in this trial
Masonic Cancer Center, University of Minnesota


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services